In Brief: MedGuide
MedGuide: Comment period for the proposed rule on medication guide requirements extended to Dec. 22, according to a Nov. 24 Federal Register notice. FDA will be sponsoring a public workshop Jan. 9-10 to "develop criteria for `useful' prescription information for patients" in concordance with HHS' Healthy People 2000 goals and FDA's medication guide proposal, a Nov. 20 "Dear Colleague" letter from FDA Associate Commissioner Office of Management Sharon Smith Holston states. The workshop will be held at NIH's Natcher Auditorium, beginning at 8 a.m. on Jan. 9 and 8:30 a.m. on Jan. 10...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth